NCT02628964View on ClinicalTrials.gov

Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 26, 2018

Study Completion Date

March 26, 2018

Conditions

Tobacco Use DisorderSmoking

Interventions

DEVICE

e-cigarettes

Participants and research assistants will be blind to the allocation of nicotine or placebo e-cigarettes as there are no difference in appearance or odor of the mist emitted from the e-cigarettes with and without nicotine containing cartridges.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER

NCT02628964 - Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy | Biotech Hunter | Biotech Hunter